Zeina Nahleh

8PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

|Jan 28, 2026
Minimal residual disease in solid tumors: Clinical applications and future directions.

Theresa Abdo, Ahmad Alhalabi, Sacha Yaghi

|Apr 07, 2023
ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology.

Gladys Rodriguez, Joan Mancuso, Gary H Lyman

|Jan 18, 2022
Use of Biosimilar Medications in Oncology.

Zeina Nahleh, Gary H Lyman, Richard L Schilsky

|Aug 27, 2021
Survival benefit of a combined surgical approach in patients with metastatic breast cancer.

Nadeem Bilani, Marita Yaghi, Iktej Singh Jabbal

|Jan 21, 2021
Male Breast Cancer: A Comparative Analysis from the National Cancer Database.

Elizabeth B Elimimian, Leah Elson, Hong Li

Pageof 2

Frequent Collaborators

3 joint publications

Nadeem Bilani

2 joint publications

Leah Elson

2 joint publications

Elizabeth Blessing Elimimian

2 joint publications

Gary H Lyman